Voyageur Pharmaceuticals Ltd.
VM.V
TSX
| 11/30/2025 | 08/31/2025 | 05/31/2025 | 02/28/2025 | 11/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 34.79% | -145.72% | 32.24% | -71.41% | -27.70% |
| Total Depreciation and Amortization | 0.00% | 0.00% | 0.00% | -33.33% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -148.38% | -14.99% | -28.26% | 2,291.47% | -124.57% |
| Change in Net Operating Assets | 225.54% | 10,461.54% | 99.81% | -283.25% | 55.57% |
| Cash from Operations | 58.84% | -247.30% | 80.76% | -4,401.34% | -21.68% |
| Capital Expenditure | 21.45% | -474.66% | 50.68% | -15.18% | 36.07% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 21.45% | -474.66% | 50.68% | -15.18% | 36.07% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -99.22% | 1,709.09% | -94.40% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -230.28% | 1.15% | -124.48% | 70.00% | -- |
| Cash from Financing | -113.46% | 7,651.70% | -98.89% | 990.61% | 2,860.98% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -217.63% | 322.18% | -156.02% | 180.10% | 1,695.95% |